# SPRIM

> SPRIM is a VC fund in Bengaluru backing Health Care and Biotechnology. See 5 investments, round sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Bengaluru, India
- Total investments: 5
- Last investment: Oct 2022
- Lead investor: 60%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/sprim-global/
- Website: http://www.sprim.com

SPRIM is a management consulting company with a venture capital division, known as SPRIM Ventures.

## Contacts

5 contacts available for SPRIM. Shizune tracks 5 team members at SPRIM. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/sprim?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 40% |
| Biotechnology | 1 | 20% |
| Service Industry | 1 | 20% |
| Health Diagnostics | 1 | 20% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 3 | 60% |
| Seed | 1 | 20% |
| Series B | 1 | 20% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 2 | 40% |
| Singapore | 1 | 20% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Dan Brenner | Chief Growth Officer | 0 | https://shizune.co/investors/profile/dan-brenner-2 |
| Ivan Jarry | Co-Founder & Managing Partner | 0 | https://shizune.co/investors/profile/ivan-jarry-b2b2 |
| Michael Shleifer | Managing Partner & Co-Founder | 4 | https://shizune.co/investors/profile/michael-shleifer-4051 |
| Olivier Shleifer | Co-Founder & Managing Partner | 0 | https://shizune.co/investors/profile/olivier-shleifer-8165 |
| Rodney Cheung | CIO | 0 | https://shizune.co/investors/profile/rodney-cheung |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Mi-Helper | Mi-Helper helps to develop a non-drug remedy for migraine and mood issues. | $4M | Series A | Oct 10, 2022 |  |
| AUM Biosciences | AUM Biosciences is an oncology-focused biotechnology company that aims to accelerate the development of innovative, affordable medicines for patients in Asia and around the world. AUM Biosciences focuses on early-stage development of innovative medicines for the treatment of Asian-prevalent cancers. | $27M | Series A | Oct 12, 2021 |  |
| ObvioHealth | ObvioHealth is a global digital health organization providing real-world digital clinical trials that deliver better data.Our mobile clinical study application allows for site-less trial design, allowing subjects to use their smartphones to participate in remote monitoring clinical trials from the comfort of their homes. For studies designed toinclude site visits, our application allows for continuous data collection in between visits to the clinic.By bringing the trial directly to the mobile device of each participant, our study team engages subjects daily using text message and chatbot features. This interaction allows for open communication and helps subjects feel involved during virtual clinical trials.The result: robust data collection, increased compliance, faster recruitment and improved time to completion.To assist with collecting real world data in clinical trials, our app can easy link to various health devices. They include Apple watches, Fitbits and activity trackers, along with Bluetooth scales, blood pressure monitors, and smart health apps.Participants can also use the app to schedule lab visits, or connect it with their PayPal account to receive compensation for decentralized clinical trials. And if the study team needs to talk with the participant during mobile clinical trials, the app allows for easy communication through chat or video.Visit Obviohealth.com to learn more about how our technology can help with observational clinical trials and virtual clinical trials. | $19.3M | Series B | Jun 08, 2021 |  |
| ObvioHealth | ObvioHealth is a global digital health organization providing real-world digital clinical trials that deliver better data.Our mobile clinical study application allows for site-less trial design, allowing subjects to use their smartphones to participate in remote monitoring clinical trials from the comfort of their homes. For studies designed toinclude site visits, our application allows for continuous data collection in between visits to the clinic.By bringing the trial directly to the mobile device of each participant, our study team engages subjects daily using text message and chatbot features. This interaction allows for open communication and helps subjects feel involved during virtual clinical trials.The result: robust data collection, increased compliance, faster recruitment and improved time to completion.To assist with collecting real world data in clinical trials, our app can easy link to various health devices. They include Apple watches, Fitbits and activity trackers, along with Bluetooth scales, blood pressure monitors, and smart health apps.Participants can also use the app to schedule lab visits, or connect it with their PayPal account to receive compensation for decentralized clinical trials. And if the study team needs to talk with the participant during mobile clinical trials, the app allows for easy communication through chat or video.Visit Obviohealth.com to learn more about how our technology can help with observational clinical trials and virtual clinical trials. | $17M | Series A | Apr 14, 2020 |  |
| ObvioHealth | ObvioHealth is a global digital health organization providing real-world digital clinical trials that deliver better data.Our mobile clinical study application allows for site-less trial design, allowing subjects to use their smartphones to participate in remote monitoring clinical trials from the comfort of their homes. For studies designed toinclude site visits, our application allows for continuous data collection in between visits to the clinic.By bringing the trial directly to the mobile device of each participant, our study team engages subjects daily using text message and chatbot features. This interaction allows for open communication and helps subjects feel involved during virtual clinical trials.The result: robust data collection, increased compliance, faster recruitment and improved time to completion.To assist with collecting real world data in clinical trials, our app can easy link to various health devices. They include Apple watches, Fitbits and activity trackers, along with Bluetooth scales, blood pressure monitors, and smart health apps.Participants can also use the app to schedule lab visits, or connect it with their PayPal account to receive compensation for decentralized clinical trials. And if the study team needs to talk with the participant during mobile clinical trials, the app allows for easy communication through chat or video.Visit Obviohealth.com to learn more about how our technology can help with observational clinical trials and virtual clinical trials. | $6M | Seed | Mar 23, 2018 |  |

5 of 5 investments shown.

## Co-investors
- [Tikehau Capital](https://shizune.co/investors/profile/tikehau-capital-advisors) — VC Fund, 2 deals together
- [Holdings](https://shizune.co/investors/profile/at-capital-group) — VC Fund, 1 deal together
- [Ayala](https://shizune.co/investors/profile/ayala-corporation) — VC Fund, 1 deal together
- [CoolTech](https://shizune.co/investors/profile/cooltech-37ad) — VC Fund, 1 deal together
- [Dedalus Group](https://shizune.co/investors/profile/dedalus-group) — VC Fund, 1 deal together
- [Everlife](https://shizune.co/investors/profile/everlife) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Seeds Capital](https://shizune.co/investors/profile/seeds-capital) — VC Fund
- [Wavemaker Ventures](https://shizune.co/investors/profile/wavemaker-partners) — VC Fund

## Featured in investor lists
- [Health Care Investors in Singapore](https://shizune.co/investors/health-care-investors-singapore)
- [Health Care VC Funds in Singapore](https://shizune.co/investors/health-care-vc-funds-singapore)
- [Biotechnology Investors in Singapore](https://shizune.co/investors/biotechnology-investors-singapore)
- [Biotech Investors in Singapore](https://shizune.co/investors/biotech-investors-singapore)

## FAQ

### What does SPRIM invest in?

SPRIM invests primarily in Health Care, Biotechnology and Service Industry startups, most often at Series A and Seed stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact SPRIM?

Public channels for SPRIM include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at SPRIM?

The team at SPRIM includes Dan Brenner (Chief Growth Officer), Ivan Jarry (Co-Founder & Managing Partner) and Michael Shleifer (Managing Partner & Co-Founder). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co